Beranda › Mieloma Multipel › Connecticut › East Norwalk
Uji klinis Mieloma Multipel di East Norwalk, CT
13 studi untuk Mieloma Multipel mencari peserta di lokasi sekitar East Norwalk (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
Menerima pesertaFase 2
- Memorial Sloan Kettering Suffolk-Commack (All Protocol Activity), Commack · 19 mi jauhnya
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
Menerima peserta
- Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack · 19 mi jauhnya
A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant
Menerima pesertaFase 2
- Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack · 19 mi jauhnya
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
Menerima pesertaFase 3
- MSK Commack, Commack · 19 mi jauhnya
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
Menerima pesertaFase 3
- MSK Commack, Commack · 19 mi jauhnya
A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma
Menerima pesertaFase 1
- Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack · 19 mi jauhnya
A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy
Menerima pesertaStudi observasional
- Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities), Commack · 19 mi jauhnya
A Study of Dara-RVd and Teclistamab-RVd in People With Multiple Myeloma
Menerima pesertaFase 1/2
- Memorial Sloan Kettering Cancer Center @ Suffolk - Commack (Limited Protocol Activities), Commack · 19 mi jauhnya
A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)
Menerima pesertaFase 2
- Memorial Sloan Kettering Cancer Center Suffolk - Commack (Limited Protocol Activities), Commack · 19 mi jauhnya
A Study of Elranatamab and Cyclophosphamide in People With Multiple Myeloma
Menerima pesertaFase 2
- Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (All Protocol Activities), Commack · 19 mi jauhnya
A Dietary Study for People With Multiple Myeloma
Menerima peserta
- Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities), Commack · 19 mi jauhnya
A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy
Menerima pesertaFase 2
- Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack · 19 mi jauhnya
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Memorial Sloan Kettering Commack, Commack · 19 mi jauhnya
Uji klinis Mieloma Multipel di kota lain
- New York City, NY60 studi
- Boston, MA42 studi
- Atlanta, GA42 studi
- Houston, TX38 studi
- Durham, NC37 studi
- Nashville, TN32 studi
- Denver, CO27 studi
- Rochester, MN24 studi
- St. Louis, MO24 studi
- Columbus, OH24 studi
- Baldwin Park, CA23 studi
- Edison, NJ22 studi
Studi lain di East Norwalk
- Kanker Payudara35 studi
- Kanker Paru Non-Sel Kecil18 studi
- Kanker Prostat16 studi
- Leukemia Mieloid Akut14 studi
- Kanker Endometrium12 studi
- Kanker Kandung Kemih10 studi
- Kanker Paru10 studi
- Kanker Ovarium10 studi
- Kanker (semua jenis)10 studi
- Limfoma8 studi
- Kanker Kolorektal8 studi
- Kanker Metastatik8 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.